| Literature DB >> 30223519 |
Pavel Horky1, Sylvie Skalickova2, Daria Baholet3, Jiri Skladanka4.
Abstract
Mycotoxins are toxic secondary metabolites produced by certain filamentous fungi. The occurrence of mycotoxins in food and feed causes negative health impacts on both humans and animals. Clay binders, yeast cell walls, or antioxidant additives are the most widely used products for mycotoxin elimination to reduce their impact. Although conventional methods are constantly improving, current research trends are looking for innovative solutions. Nanotechnology approaches seem to be a promising, effective, and low-cost way to minimize the health effects of mycotoxins. This review aims to shed light on the critical knowledge gap in mycotoxin elimination by nanotechnology. There are three main strategies: mold inhibition, mycotoxin adsorption, and reducing the toxic effect via nanoparticles. One of the most promising methods is the use of carbon-based nanomaterials. Graphene has been shown to have a huge surface and high binding capacity for mycotoxins. Attention has also been drawn to polymeric nanoparticles; they could substitute adsorbents or enclose any substance, which would improve the health status of the organism. In light of these findings, this review gives new insights into possible future research that might overcome challenges associated with nanotechnology utilization for mycotoxin elimination from agricultural products.Entities:
Keywords: agriculture; mycotoxin; nanoparticles; nanotechnology; toxicity
Year: 2018 PMID: 30223519 PMCID: PMC6164963 DOI: 10.3390/nano8090727
Source DB: PubMed Journal: Nanomaterials (Basel) ISSN: 2079-4991 Impact factor: 5.076
Figure 1Different immunodetection arrangements. (a) An electrosensor based on the interaction of the antibody with mycotoxin, which amplifies the signal; (b) A lateral easy-to-use immunoassay for the detection of mycotoxins by the naked eye. Figures adapted from [37,42], with permission from Elsevier (2017) and John Wiley and Sons (2015), respectively.
Antifungal nanoparticles synthetized by the chemical route.
| Organism | Type of Particles | Inhibition Dose | Average Size | Reference |
|---|---|---|---|---|
|
| Silver nanoparticles | 100 ppm | NA | [ |
|
| Silver nanoparticles | 10 ppm | 14 nm | [ |
| PEGylated Mancozeb | 3 mg/L | NA | [ | |
|
| Thyme essential oils in chitosan-benzoic acid nanogel | 300 mg/L | 100 nm | [ |
|
| Menthe piperita essential oils in chitosan-cinnamic acid nanogel | 500 ppm | 100 nm | [ |
|
| Cuminum cyminum essential oils in chitosan-caffeic acid nanogel | 650 ppm | 100 nm | [ |
|
| Nanodispersed Cinnamaldehyde by surfactant (Tween 80) | 1.0 mM | 60 nm | [ |
|
| Silver nanoparticles | 5 μg/mL | 4.5 nm | [ |
|
| Titanium dioxide nanoparticles | 1 g/L | 30 nm | [ |
|
| Silver-, copper-, and nickel-based nanoparticles | 65 μg/mL | 15 nm | [ |
|
| Pullulan and silver nanoparticles | 1.7 mg/g | 9 nm | [ |
|
| Citrate-coated silver nanoparticles | 50 ng/mL | 20 nm | [ |
|
| Silver nanoparticles | 180 μg/mL | NA | [ |
|
| Silver nanoparticles | 20 mg/L | 35 nm | [ |
|
| Chitosan nanoparticles | 5000 ppm | 200 nm | [ |
|
| Chitosan silver nanocomposites | 100 μg/mL | 370 nm | [ |
|
| Alumina nanoparticles | 400 mg/L | 200 nm | [ |
|
| Ag-doped Titan oxide nanoparticles | 0.43 mg/plate | NA | [ |
| Zinc oxide nanoparticles | 3 mmol/L | 70 nm | [ | |
| Copper nanoparticles | 20 and 60 μg/mL | NA | [ | |
|
| Silica and silver nanoparticles | 5–100 ppm | 0.65 nm and 200 nm | [ |
| Zinc oxide nanoparticles | 5 mg/mL | 600 nm | [ |
Antifungal green synthetized nanoparticles.
| Organism | Mediator | Type of Particles | Inhibition Dose | Average Size | Reference |
|---|---|---|---|---|---|
| Aloe vera leaf extract | Ag | 100 μL of 1 M | 70 nm | [ | |
|
| Ag | 3 and 9 g/100 mL | 20 nm | [ | |
|
| CuO | 1000 ppm | 30 nm | [ | |
|
|
| Ag | 4000 ppm | 54 nm | [ |
| Se | 100 μg/mL | 140 nm | [ | ||
|
| Ag | 1 mg/mL | 15 nm | [ | |
|
|
| Ag | 500 mg/L | 15 nm | [ |
Figure 2Key properties of carbon nanoparticles such as fullerenes, carbon nanotubes, and graphene (native graphene (G), reduced graphene (rGO), and graphene oxide (GO)). Mycotoxins can be bound to the surface, bundles, grooves, or channels between nanoparticles via different binding interactions.
Figure 3Scheme of the quercetin (Q)-loaded chitosan (CS) nanoparticle mechanism of action. The relaxed polysaccharide structure of the chitosan is crosslinked with tripolyphosphate (TPP). The Q is entrapped in the CS structure. The positive charge of NPs electrostatically interacts with the negatively charged epithelial cell wall. Quercetin triggers a hepato-protective cascade that leads to antioxidant protection via stimulation of nuclear factor E2-related factor 2 (Nrf2)-induced heme-oxygenase-1 (HO-1) production. Transcriptional response is mediated by the acting element termed (ARE) found in the promoters of genes encoding the detoxication enzymes. Q-inhibited lipopolysacharide (LPS) induced nitric oxide synthase (iNOS) and NO production via IκB kinase (IKK) and p38 mitogen-activated protein kinases (p38MAPK). The proposed mechanism of action of quercetin is adapted from [166], with permission from Public Library of Science, 2015.
Binding capacity and dose evaluated as safe in mouse models for selected mycotoxin nanoadsorbents.
| Nanostructure | Preparation Method | Ref. | USD/g | Dose Evaluated as a Safe in Mouse Models | Ref. | Mycotoxin | Binding Capacity | Ref. |
|---|---|---|---|---|---|---|---|---|
| Nanodiamonds | ion and laser bombarding, CVD, hydrothermal, ultrasonic, electrochemical | [ | 20–100 | <25 mg/kg | [ | AFL | 10 μg/mg | [ |
| OTA | 15 μg/mg | |||||||
| Magnetic graphene oxide | coprecipitation, covalent bonding, electrostatic self–assembly, impregnating graphene oxide with magnetic nanoparticles | [ | 8–20 | 0.3 mg/kg | [ | DON, ZEA | 0.065 μg/mg | [ |
| Surface active maghemite nanoparticles | coprecipitation, sol–gel synthesis, microemulsion, flow injection synthesis, hydrothermal synthesis, flame spray pyrolysis, decomposition of organic precursors at high temperatures, oxidation of magnetite nanoparticles | [ | 20–100 | <10 mg Fe/kg | [ | Citrin | 175 μg/mg | |
| Chitosan nanoparticles | ionotropic gelation, microemulsion, emulsification solvent diffusion, polyelectrolyte complex, reverse micellar method | [ | 1–5 | 16,000 mg/kg | [ | AFL | 0.8 μg/mg | [ |
| ZEA, OTA | 1 μg/mg | |||||||
| Montmorillonite nanocomposite | hot intercalation technique, in situ polymerization, solution induced intercalation 10, melt processing | [ | 1–5 | 1000 mg/kg | [ | AFL | 67 μg/mg | [ |
| Modified halloysite nanotubes | naturally occuring | [ | <1 | 10 mg/mL | [ | ZEA | 1000 μg/mg | [ |